ANGPT2 and metabolic dysfunction-associated steatohepatitis: Meanwhile, Lefere et al. showed that pharmacological inhibition of the angiopoietin-2 (Ang-2)/Tie2 interaction improved vascular morphology and ameliorated steatohepatitis in MCD-induced murine NASH [82].